Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 54,335 shares, a growth of 150.5% from the October 15th total of 21,689 shares. Based on an average daily trading volume, of 428,051 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are short sold.
Terumo Trading Up 2.3%
Shares of Terumo stock traded up $0.34 during trading hours on Friday, reaching $15.02. The stock had a trading volume of 15,838 shares, compared to its average volume of 232,874. The firm has a market capitalization of $22.15 billion, a price-to-earnings ratio of 21.15 and a beta of 0.82. Terumo has a 1 year low of $12.08 and a 1 year high of $16.81. The company has a current ratio of 2.19, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. The firm has a 50 day simple moving average of $14.81 and a two-hundred day simple moving average of $14.08.
Terumo (OTCMKTS:TRUMY – Get Free Report) last issued its earnings results on Thursday, November 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.06). The firm had revenue of $1.96 billion for the quarter, compared to analysts’ expectations of $1.94 billion. Terumo had a return on equity of 10.44% and a net margin of 13.83%. As a group, equities research analysts anticipate that Terumo will post 0.86 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts have issued reports on TRUMY shares. Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. Zacks Research raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 13th. Two investment analysts have rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, Terumo presently has a consensus rating of “Strong Buy”.
Check Out Our Latest Analysis on TRUMY
About Terumo
Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.
Featured Stories
- Five stocks we like better than Terumo
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
- Firefly Aerospace Lights Up a High-Risk Space Opportunity
- Is Buying the NVIDIA Dip a Mistake? 3 Value Stocks Offer a Different Path Forward
- Costco’s Record $30 Dividend Shows Just How Strong Its Cash Machine Is
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.
